Pharmabiz

BDCDA seeks reconsideration of Karnataka Drugs & Cosmetics Rules Amendments

BDCDA seeks reconsideration of Karnataka Drugs & Cosmetics Rules Amendments: Nandita Vijayasimha, Bengaluru Saturday, January ...
Pharmabiz

NIHR leaders and researchers recognised in King’s New Year Honours

NIHR leaders and researchers recognised in King’s New Year Honours: United Kingdom Saturday, January 10, 2026, 12:00 Hrs [IST] National Institute for Health and Care Research (N ...
Pharmabiz

Just-Evotec Biologics receives Gates Foundation grant for AI-driven optimization of monoclonal antibody developability for affordable access

Just-Evotec Biologics receives Gates Foundation grant for AI-driven optimization of monoclonal antibody developability for affordable access: Hamburg, Germany Saturday, January 10 ...
Pharmabiz

Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm

Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm: Grenoble, France Saturday, January 10, 2026, 10:00 Hrs [IST] Diabeloop, a global com ...
Pharmabiz

Organon partners with Daiichi Sankyo for commercialization of Nilemdo in France, Denmark, Iceland, Sweden, Finland & Norway

Jersey City, New Jersey Saturday, January 10, 2026, 09:00 Hrs [IST] ...
Pharmabiz

Panel asks Ayush Ministry to come out with detailed strategic plans to achieve $200 billion market capitalisation

Gireesh Babu, New Delhi Saturday, January 10, 2026, 08:00 Hrs [IST] ...
Pharmabiz

Pronto Consult observes India’s 2025 healthcare shift from reactive protection to aspirational prevention

Pronto Consult observes India’s 2025 healthcare shift from reactive protection to aspirational prevention: Peethaambaran Kunnathoor, Chennai Saturday, January 10, 2026, 08:00 Hr ...
Pharmabiz

Panel asks Ayush Ministry to intensify efforts to clear pending Utilisation Certificates

Panel asks Ayush Ministry to intensify efforts to clear pending Utilisation Certificates: Gireesh Babu, New Delhi Saturday, January 10, 2026, 08:00 Hrs [IST] Raising concerns over ...
Opinion
PharmabizOpinion

Experts recommend eliminating inverted duty structure, incentives for research in Union Budget 2026

Experts recommend eliminating inverted duty structure, incentives for research in Union Budget 2026: Shardul Nautiyal, Mumbai Saturday, January 10, 2026, 08:00 Hrs [IST] Experts h ...
Pharmabiz

Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC

Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...
Pharmabiz

Basilea Pharmaceutica inks agreement with Prokaryotics to develop a novel broad-spectrum antifungal to treat severe invasive infections

Allschwil, Switzerland Friday, January 9, 2026, 13:00 Hrs [IST] ...
Pharmabiz

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting: Our Bureau, Bengaluru Friday, January 9, 2026, 12:15 Hrs [IST] Shilp ...